LEGIPID® Legionella Fast Detection

LEGIPID® Legionella Fast Detection is a groundbreaking biotechnology startup established in 2005 in Spain. Promoting environmental and human health, the company has developed cutting-edge fast microbial detection techniques, particularly focusing on Legionella detection. Their product, Legipid, stands out as the only internationally certified kit for the rapid detection of Legionella, holding the prestigious certification from the AOAC Research Institute (certificate #111101).

Biótica's mission is to empower clients to timely assess microbiological risks and optimize prevention strategies through fast, reliable, simple, and cost-effective testing. The company's innovative approach integrates immunomagnetic capture and enzyme immunoassay (C.E.I.A.), garnering attention from various sectors including industries, commercial/private labs, physician offices, public health labs, hospitals, hotels, spas, jacuzzis, swimming pools, recreational areas, sport areas (e.g., golf), and more.

Furthermore, with a recent €700.00K Series C investment secured on 03 June 2016, the company has demonstrated its potential to attract substantial backing. Notably, Caixa Capital Risc emerged as the primary investor, recognizing the promising trajectory of Biótica and its pioneering solutions. In the ever-evolving landscape of biotechnology, Biótica continues to be a compelling player, offering advanced technologies that have the potential to transform microbial detection and prevention strategies across various industries.